MedTrace Logo

Efficacy of Vitamin D3 for the Treatment of Psoriatic Patients With Vitamin D Deficiency and Insufficiency

NCT01339741 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2011-04-21

No results posted yet for this study

Summary

The purpose of this research is to study whether vitamin D supplement can improve clinical outcome (PASI score) in psoriasis vulgaris with vitamin D insufficiency and deficiency.

Conditions

  • Psoriasis Vulgaris
  • Vitamin D Deficiency

Interventions

DIETARY_SUPPLEMENT

Vitamin D3

Vitamin D3, oral supplement, 12 weeks

DRUG

Placebo

Placebo, oral route, 12 weeks

Sponsors & Collaborators

  • Chulalongkorn University

    lead OTHER

Principal Investigators

  • Chotinij Lertphanichkul, M.D. · Chulalongkorn University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2012-02-29
Completion
2012-02-29

Countries

  • Thailand

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01339741 on ClinicalTrials.gov